Pharmacogenomic and Bioinformatic Insights into ACE Gene Variants and Their Influence on ACE Inhibitor Response in Hypertension
Main Article Content
Abstract
Response to angiotensin-converting enzyme inhibitors (ACEIs)-based antihypertensive therapy varies between individuals, which is largely influenced by genetic factors. The ACE gene has several polymorphisms that can affect enzyme levels and therapeutic efficacy. This study aims to explore the relationship between genetic variations in the ACE gene and response to captopril, lisinopril, ramipril, and enalapril in hypertensive patients. This study used a bioinformatics and pharmacogenomics approach by analyzing data from PharmGKB, Ensembl, and GTEx Portal. Genetic polymorphisms were analyzed to evaluate their association with ACEI efficacy using a descriptive statistical approach. Results: Four single nucleotide polymorphisms (SNPs) in the ACE gene were found to be associated with response to ACEI. Variants rs4291 and rs1799752 were associated with captopril efficacy, where the AA genotype showed a decrease in the severity of renal failure. The rs1799752 variant was also associated with lisinopril and enalapril, with the DD genotype providing greater blood pressure reduction. In addition, rs4359 and rs4344 were correlated with the efficacy of ramipril, especially in the CC+TT and AA+GG genotypes. Genetic variation in the ACE gene plays a role in determining the response to ACEI therapy. Pharmacogenetic approaches have the potential to improve the efficacy and safety of antihypertensive treatment.
Article Details
References
Nojiri S, Daida H. Atherosclerotic Cardiovascular Risk in Japan. Jpn Clin Med. 2017 Jun 19;8:1179066017712713. doi: 10.1177/1179066017712713. PMID: 28680271; PMCID: PMC5480958.
El-Setouhy M, Safhi AM, Dallak MY, Ayoub AY, Suwaid OAH, Moafa AK, Al-Ahmed AM, Zaino M, Al Sayed A. Prevalence and associated factors of pediatric hypertension in Jazan region, south of the Kingdom of Saudi Arabia. A pilot cross-sectional study. PLoS One. 2023 Jul 10;18(7):e0287698. doi: 10.1371/journal.pone.0287698. PMID: 37428728; PMCID: PMC10332581.
Kumar, V., Agarwal, S., Saboo, B. & Makkar, B. RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus. Int J Diabetes Dev Ctries 42, 576–605 (2022).
Zheng, W. et al. Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective. Frontiers in Pharmacology vol. 13 Preprint at https://doi.org/10.3389/fphar.2022.968104 (2022).
Hu, Y., Liang, L., Liu, S., Kung, J. Y. & Banh, H. L. Angiotensin-converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: A systematic review, and network meta-analysis. J Clin Hypertens 25, 661–688 (2023).
Baek, R. C. et al. The influence of a polymorphism in the gene encoding angiotensin converting enzyme (ACE) on treatment outcomes in late-onset Pompe patients receiving alglucosidase alfa. Mol Genet Metab Rep 8, 48–50 (2016).
Meurs, K. M. et al. Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism. JRAAS - Journal of the Renin-Angiotensin-Aldosterone System 18, 1–4 (2017).
Leisman, D. E. et al. ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock. Crit Care 28, (2024).
Amukti, D. P., Irham, L. M., Pratami, R. I. & Adikusuma, W. Identifying Gene Variants That Are Pathogenic In Osteoporosis Using An Omics Data And Bioinformatics Approach. Biomedical Journal of Indonesia 10, 104–111 (2024).
Gumelar, G. et al. Harnessing Genomic and Bioinformatic Data to Broaden Understanding of Leukaemia Across Continents. Scripta Medica (Banja Luka) 55, 717–725 (2024).
Irham, L. M. et al. Trends in drug repurposing for chronic hepatitis-B infection:bibliometric-basedapproach1990-2024. in BIO Web of Conferences vol. 148 (EDP Sciences, 2025).
Amukti, D. P. et al. Genomic variants and epidemiology of atherosclerosis – worldwide correlation analysis and utilization of atherosclerosis gene variants for identification of drug target candidates with bioinformatics approach. Bulgarian Cardiology 30, 108–120 (2024).
Prasetyaning Amukti, D., Indah Pratami, R. & Gumelar, G. Tinjauan Literatur tentang Hubungan Mutasi Genetik dengan Resistensi Obat pada Mycobacterium Tuberculosis. Journal of Pharmacy and Halal Studies 2, 6–12 (2024).
Made, I. et al. POTENSI VARIASI GEN FGL1 DALAM PENINGKATAN RISIKO EFEK SAMPING PADA HATI AKIBAT PENGGUNAAN NIFEDIPIN PADA PASIEN HIPERTENSI GESTASIONAL. Jurnal Ilmu Farmasi dan Farmasi Klinik (JIFFK) 21, 269–276 (2024).
Irham, L. M. et al. Applied of bioinformatics in drug discovery and drug development: bioinformatic analysis 1996-2024. in BIO Web of Conferences vol. 148 (EDP Sciences, 2025).
Irham, L. M. et al. Applied of bioinformatics in drug discovery and drug development: bioinformatic analysis 1996-2024. in BIO Web of Conferences vol. 148 (EDP Sciences, 2025).
Humolungo DT, Anjani R, Irham LM, Sulistyani N, Ma’ruf M, Amukti DP, Adikusuma W, Sarasmita MA, Khairi S, Purwanto BD, Suyatmi S. Identification of pathogenic gene variants in carpal tunnel syndrome using bioinformatics approaches. InE3S Web of Conferences 2024 (Vol. 501, p. 01022). EDP Sciences.
Gumelar, G. et al. Harnessing Genomic and Bioinformatic Data to Broaden Understanding of Leukaemia Across Continents. Scripta Medica (Banja Luka) 55, 717–725 (2024).
Wahyuningtyas, N., Amukti, D. P., Nurani, L. H. & Salamah, N. Efek Imunomodulator Ekstrak Etanol Akar Pasak Bumi (Eurycoma Longifolia, Jack) terhadap Ekspresi CD57 pada Hepar Tikus yang Diberi Doksorubisin. Jurnal Pharmascience 11, 304 (2024).
Prasetyaning Amukti, D., Indah Pratami, R. & Gumelar, G. Tinjauan Literatur tentang Hubungan Mutasi Genetik dengan Resistensi Obat pada Mycobacterium Tuberculosis. Journal of Pharmacy and Halal Studies 2, 6–12 (2024).
Saad, H. et al. The Role of Angiotensin Converting Enzyme 1 Insertion/Deletion Genetic Polymorphism in the Risk and Severity of COVID-19 Infection. Front Med (Lausanne) 8, (2021).
Fricke-Galindo, I. et al. The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients. Int J Mol Sci 24, (2023).
Kumari, [, Sharma, S., Thakur, N., Mondal, S. R. & Saraswathy, P. R. Beneficial Role of D Allele in Controlling ACE Levels: A Study among Brahmins of North India. J. Genet vol. 95 (2016).
Masilela, C., Adeniyi, O. V. & Benjeddou, M. Single Nucleotide Polymorphisms in Amlodipine-Associated Genes and Their Correlation with Blood Pressure Control among South African Adults with Hypertension. Genes (Basel) 13, (2022).
Anthony, E. G., Richard, E., Lipkowitz, M. S. & Bhatnagar, V. Association of the ADRB2 (rs2053044) polymorphism and angiotensin-converting enzyme-inhibitor blood pressure response in the African American Study of Kidney Disease and Hypertension. Pharmacogenet Genomics 25, 444–449 (2015).
Volpe, M. & Gallo, G. To whom recommend intensive treatment for hypertension? European Heart Journal, Supplement 22, E167–E172 (2020).
Liang, J., Ma, X. & Liang, G. Transesophageal echocardiography: Revolutionizing perioperative cardiac care. Biomolecules and Biomedicine (2024) doi:10.17305/bb.2024.10847.
Humolungo, D. T. W. S. et al. Identification of pathogenic gene variants in carpal tunnel syndrome using bioinformatics approaches. in E3S Web of Conferences vol. 501 (EDP Sciences, 2024).
Amukti, D. P. et al. Identifying pathogenic variants associated with Alzeimer by integrating genomic databases and bioinformatics approaches. in E3S Web of Conferences vol. 501 (EDP Sciences, 2024).